6505--Ipsen Biopharmaceuticals, Inc., dba Tercica, Inc. 65IB 36F79726D0137 Effective: 06/01/2026-05/31/2031

The contract awarded to Ipsen Biopharmaceuticals, Inc., dba Tercica, Inc., under solicitation number 36F79726D0137, is a five-year Federal Supply Schedule agreement with the Department of Veterans Affairs, effective from June 1, 2026, through May 31, 2031. Valued at $760,715,800, the contract falls under NAICS code 325412 for pharmaceutical preparation manufacturing and is associated with Product Service Code 6505, indicating the provision of pharmaceutical products. Performance is to occur at the VA’s National Acquisition Center in Hines, Illinois, where the contracting office is located, and all administrative and payment inquiries are to be directed to the VA Federal Supply Schedule Help Desk via email or phone. The contract does not specify whether it includes options, nor are detailed line items, pricing structures, delivery schedules, or technical specifications provided in the available documentation. While the award notice confirms the awardee’s Unique Entity ID and explicitly states that Recovery Act funds were not utilized, no information is provided regarding small business status, socioeconomic certifications, or specific quality or regulatory standards such as FDA or USP compliance. The contract is administered under the VA’s FSS framework, typically functioning as a multiple-award, indefinite-delivery mechanism, though the precise contract type is not stated. No clause-level details from Section I, special requirements from Section H, packaging specifications from Section D, inspection criteria from Section E, or attachment listings from Section J are included in the provided data, suggesting that comprehensive technical and operational terms reside in unattached or unindexed documents. All communications related to this contract must be directed through the designated FSS Help Desk, as no individual contracting officer or technical representative information is disclosed.